Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Minna Purokivi"'
Autor:
Eeva Saari, Minna Mononen, Hannele Hasala, Hanna Nurmi, Hannu-Pekka Kettunen, Sanna Suoranta, Elisa Lappi-Blanco, Riitta Kaarteenaho, Minna Purokivi, Heikki Olavi Koskela
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Interstitial lung diseases (ILD) include a wide range of diseases impacting lung parenchyma and leading to fibrosis and architectural distortion. Chronic cough and dyspnea are common symptoms which affect the quality of life (QoL)
Externí odkaz:
https://doaj.org/article/f4a89e6e437548fe93aa624bc75c0af9
Autor:
Eeva Saari, Minna Mononen, Hannele Hasala, Anne Lätti, Johanna Kaulamo, Hanna Nurmi, Riitta Kaarteenaho, Minna Purokivi, Heikki O Koskela
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Most patients with idiopathic pulmonary fibrosis (IPF) complain of cough. IPF-associated cough is widely characterized as dry or non-productive. The aim of this study was to compare chronic cough in early stage IPF patients to cou
Externí odkaz:
https://doaj.org/article/0a61811badb04d9a8354b863027132e4
Autor:
Minna Mononen, Eeva Saari, Hannele Hasala, Hannu-Pekka Kettunen, Sanna Suoranta, Hanna Nurmi, Miia Kärkkäinen, Tuomas Selander, Jukka Randell, Jari Laurikka, Toomas Uibu, Heikki Koskela, Riitta Kaarteenaho, Minna Purokivi
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background The disease course of idiopathic pulmonary fibrosis (IPF) is progressive and occasionally, other types of interstitial lung disease (ILD) may progress similarly to IPF. This study aimed to evaluate risk factors for disease progres
Externí odkaz:
https://doaj.org/article/d80b85f2ee114835bcb245f6a4ffa644
Autor:
Johanna Salonen, Hanna Nurmi, Ulla Hodgson, Hannele Hasala, Maritta Kilpeläinen, Maria Hollmen, Minna Purokivi, Riitta Kaarteenaho
Publikováno v:
European Clinical Respiratory Journal, Vol 10, Iss 1 (2023)
ABSTRACTMultidisciplinary meeting (MDM) is a core element in the diagnosis of interstitial lung diseases (ILD). The aim of the study was to investigate the implementation and key elements related to ILD MDMs in Finnish specialized care, which is char
Externí odkaz:
https://doaj.org/article/2ab3e45e5ac140a08b884eb424e81fda
Publikováno v:
BMJ Open Respiratory Research, Vol 9, Iss 1 (2022)
Introduction The previous data concerning the prevalence of idiopathic pulmonary fibrosis (IPF) and the frequency of antifibrotic drug use in Finland were based on research registries and medical records whereas nationwide data on the number of patie
Externí odkaz:
https://doaj.org/article/2a3bd8688af74fa19c2db644c835c514
Autor:
Miia Kärkkäinen, Hannu-Pekka Kettunen, Hanna Nurmi, Tuomas Selander, Minna Purokivi, Riitta Kaarteenaho
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial pneumonia with an unpredictable course. The aims of this study were to retrospectively re-evaluate a cohort of patients with IPF according to the 2011 international
Externí odkaz:
https://doaj.org/article/a287b5f759f0490b9d1123cca5f01dec
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BackgroundThe aim of this study was to compare the clinical characteristics, causes of death and factors impacting on the prognosis of patients with idiopathic pulmonary fibrosis (IPF) and other fibrosing interstitial lung disease (FILD) with a histo
Externí odkaz:
https://doaj.org/article/3e8ce93e22e8479ba94492e140c09d69
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242860 (2020)
Acute exacerbation of ILD (AE-ILD) is a common reason for hospitalization; it is also associated with significant mortality. Less is known about the prognostic significance of other events causing acute, non-elective hospitalizations in ILD patients.
Externí odkaz:
https://doaj.org/article/685996bce9d847b79e1093459b4a9447
Autor:
Miia Kärkkäinen, Hanna Nurmi, Hannu-Pekka Kettunen, Tuomas Selander, Minna Purokivi, Riitta Kaarteenaho
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The most common cause of death of patients with idiopathic pulmonary fibrosis (IPF) has been reported to be the lung disease itself and mortality from IPF appears to be increasing. However, the causes of death in patients with IPF
Externí odkaz:
https://doaj.org/article/4c5bd85b7b714668a498b5d3f22963d4
Autor:
Vincent Cottin, Dirk Koschel, Andreas Günther, Carlo Albera, Arata Azuma, C. Magnus Sköld, Sara Tomassetti, Philip Hormel, John L. Stauffer, Indiana Strombom, Klaus-Uwe Kirchgaessler, Toby M. Maher, PASSPORT study group, Peter Cerkl, Holger Flick, Christian Geltner, Judith Löffler-Ragg, Michael Studnicka, Elisabeth Bendstrup, Helle Dall Madsen, Saher B. Shaker, Maritta Kilpelainen, Marjukka Myllaerniemi, Minna Purokivi, Seppo Saarelainen, Emmanuel Bergot, Philippe Bonniaud, Raphael Borie, Pascal Chanez, Francis Couturaud, Claire Dromer, Frederic Gagnadoux, Anne-Sophie Gamez, Anne Gondouin, Dominique Israel-Biet, Stephane Jouneau, Romain Kessler, Francois Lebargy, Sylvain Marchand-Adam, Borsi Melloni, Jean-Marc Naccache, Christophe Pison, Gregoire Prevot, Martine Reynaud-Gaubert, Abdellatif Tazi, Dominique Valeyre, Benoit Wallaert, Jost Achenbach, Stefan Andreas, Burkhard Bewig, Reiner Bonnet, Stephan Budweiser, Ulrich Costabel, Martin Faehling, Joachim Ficker, Juergen Fisher, Sven Glaeser, Christian Grah, Christian Grohe, Martin Hetzel, Wolfgang Hohenforst-Schmidt, David Jungck, Peter Kardos, Claus Keller, Martin Kohlhaeufl, Claus Kroegel, Rainer Kruegel, Berthold Michels, Joachim Mueller-Quernheim, Claus Neurohr, Heinz-Theodor Pelzer, Michael Pfeifer, Michael Prediger, Klaus F. Rabe, Winifried Randerath, Nicolas Scheonfeld, Robert Scheubel, Jens Schreiber, Hartwig Schutte, Bernd Schoenhofer, Barbara Wagener, Tobias Welte, Michael Westhoff, Heinrike Wilkens, Hubert Wirtz, Michael Henry, Michael Keane, Anthony O'Regan, Katherine O'Reilly, Fabrizio Luppi, Sandra Nutini, Alberto Pesci, Venerino Poletti, Elisabetta Rosi, Paola Rottoli, Thomas Eagan, Durdica Kulosman, Tone Blorg Sjaheim, Karl Axel Karlsson, Magnus Sköld, Sanjay Agrawal, Kesavan Suresh Babu, Stephen Bianchi, Nazia Chaudhuri, Sophie Fletcher, Michael Gibbons, Simon Hart, Gisli Jenkins, Toby Maher, Ann Millar, Joanna Porter, Nicky Simler, Lisa Spencer, Monica Spiteri, Melissa Wickremasinghe
Publikováno v:
ERJ Open Research, Vol 4, Iss 4 (2018)
Real-world studies include a broader patient population for a longer duration than randomised controlled trials (RCTs) and can provide relevant insights for clinical practice. PASSPORT was a multicentre, prospective, post-authorisation study of patie
Externí odkaz:
https://doaj.org/article/bc7d2efc99fe4cf088e6bcb6fe363782